Patient-reported symptom burden as a prognostic factor in treatment with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial. (Record no. 30542306)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02265 a2200637 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518081855.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202104s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2045-7634 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1002/cam4.2826 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ooki, Akira |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20210423 |
| 245 00 - TITLE STATEMENT | |
| Title | Patient-reported symptom burden as a prognostic factor in treatment with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cancer medicine |
| Date of publication, distribution, etc. | 03 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1779-1789 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cetuximab |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Colorectal Neoplasms |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug-Related Side Effects and Adverse Reactions |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kaplan-Meier Estimate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Patient Reported Outcome Measures |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Progression-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Quality of Life |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Response Evaluation Criteria in Solid Tumors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Self Report |
| General subdivision | statistics & numerical data |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Severity of Illness Index |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Morita, Satoshi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Iwamoto, Shigeyoshi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hara, Hiroki |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tanioka, Hiroaki |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Satake, Hironaga |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kataoka, Masato |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kotaka, Masahito |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kagawa, Yoshinori |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nakamura, Masato |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shingai, Tatsushi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ishikawa, Masashi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Miyake, Yasuhiro |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Suto, Takeshi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hashiguchi, Yojiro |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yabuno, Taichi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sakamoto, Junichi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tsuji, Akihito |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ando, Masahiko |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yamaguchi, Kensei |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cancer medicine |
| Related parts | vol. 9 |
| -- | no. 5 |
| -- | p. 1779-1789 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1002/cam4.2826">https://doi.org/10.1002/cam4.2826</a> |
| Public note | Available from publisher's website |
No items available.